drj logo

"*" indicates required fields

Name*
Address*
Password*
I agree to the Terms of Service and Privacy Policy*
Yes, of course I want to receive emails from DRJ!
This field is for validation purposes and should be left unchanged.

Already have an account? Log in

drj logo

Welcome to DRJ

Already registered user? Please login here

Login Form

Register
Forgot password? Click here to reset

Create new account
(it's completely free). Subscribe

x
Skip to content
Disaster Recovery Journal
  • EN ESPAÑOL
  • SIGN IN
  • SUBSCRIBE
  • THE JOURNAL
    • Why Subscribe to DRJ
    • Digital Edition
    • Article Submission
    • DRJ Annual Resource Directories
    • Article Archives
    • Career Spotlight
  • EVENTS
    • DRJ Fall 2023
    • DRJ Spring 2024
    • DRJ Spring 2024 – Call for Papers
    • Other Industry Events
    • Schedule & Archive
    • Send Your Feedback
  • WEBINARS
    • Upcoming Webinars
    • On Demand
  • MENTOR PROGRAM
  • DRJ ACADEMY
    • DRJ Academy
    • Beginner’s Guide to BC
  • RESOURCES
    • New to Business Continuity?
    • White Papers
    • DR Rules and Regs
    • Planning Groups
    • Business Directory
    • Business Resilience Decoded
    • DRJ Glossary of Business Continuity Terms
    • Careers
  • ABOUT
    • Advertise with DRJ
    • DE&I
    • Board and Committees
      • Executive Council Members
      • Editorial Advisory Board
      • Career Development Committee
      • Glossary Committee
      • Rules and Regulations Committee
  • Podcast

Journal of Allergy and Infectious Disease Review Confirms Nasal Hygiene Options Are Effective Tools as Part of Multilayered Defense Against COVID-19

by DRJ Editorial Team | February 25, 2021 | | 0 comments

Xlear Applauds Study

AMERICAN FORK, Utah–(BUSINESS WIRE)–#covid–A new review published in the highly regarded Journal of Allergy and Infectious Disease finds that nasal hygiene options (such as nasal sprays) are effective tools in combating COVID-19 pandemic—as part of a multilayered defense against the virus.

The authors conclude: “Limited strategies are currently accessible in modifying the viral content in infected patients’ respiratory tracts, justifying the need for novel therapeutic interventions targeting the principal route of infection. We propose that intranasal administration of virucidal and antiviral therapies may be a novel strategy to provide an added clinical benefit by decreasing the viral activity in the nasal pathway, thus preventing disease transmission, managing the disease severity and limiting complications.”

The authors indicate that the public health officials, in the US and around the world, should be encouraging people to use nasal sprays, along with other efforts (e.g., masks, social distancing, and handwashing) to counter the spread of the virus.

The authors also call the results of another Study of the use of one such nasal spray in treating COVID-19 patients as follows: “Remarkable results including a reduction of clinical course and noted improvement of symptoms as early as day 4. Furthermore, on day 7, patients tested negative on repeat RT-PCR nasopharyngeal swab instead of the average 14-day period of negativization of COVID-19. By using xylitol plus GSE in the form of an intranasal spray. . . the time to negativization was reduced by 50%.” The nasal spray administered in that study was Xlear…which is available at almost all pharmacies, grocery stores, and natural retailers in the USA and is also available worldwide.

https://probiologists.com/Uploads/Articles/11_637497463703161509.pdf

Contacts

Jeff Gulko

617.304.7339

jeff@thegulkogroup.com

Related Content

  1. Disaster Recovery Journal
    Prevention of Communicable Diseases after Disaster
  2. Disaster Recovery Journal
    Getting Ready for the Unthinkable: Pandemic & Infectious Disease Pandemic Planning
  3. Disaster Recovery Journal
    Getting Ready for the Unthinkable: Pandemic & Infectious Disease Pandemic Planning

Recent Posts

New Individual Paid Sick Days for BMWED

September 18, 2023

Rambus Added to PHLX Semiconductor Sector Index (SOX)

September 18, 2023

Paycom Recognized as an American Hospital Association Preferred Cybersecurity Provider

September 18, 2023

EnerSys Awarded $92M Long-Term Contract With the United States Navy for Thin Plate Pure Lead (TPPL) Batteries

September 18, 2023

ScanSource Board Member Peter Browning Recognized with NACD Lifetime Achievement Award

September 18, 2023

Domo and Regional One Health Named 2023 Nucleus ROI Award Winners

September 18, 2023

Archives

  • September 2023 (587)
  • August 2023 (1202)
  • July 2023 (956)
  • June 2023 (1245)
  • May 2023 (1206)
  • April 2023 (1145)
  • March 2023 (1336)
  • February 2023 (1154)
  • January 2023 (1391)
  • December 2022 (1144)
  • November 2022 (1595)
  • October 2022 (1574)
  • September 2022 (1571)
  • August 2022 (1581)
  • July 2022 (1365)
  • June 2022 (1711)
  • May 2022 (1651)
  • April 2022 (1618)
  • March 2022 (1924)
  • February 2022 (1549)
  • January 2022 (1472)
  • December 2021 (1446)
  • November 2021 (1835)
  • October 2021 (1777)
  • September 2021 (1697)
  • August 2021 (1661)
  • July 2021 (1566)
  • June 2021 (1768)
  • May 2021 (1666)
  • April 2021 (1798)
  • March 2021 (1907)
  • February 2021 (1038)
  • January 2021 (554)
  • December 2020 (30)
  • November 2020 (35)
  • October 2020 (48)
  • September 2020 (57)
  • August 2020 (52)
  • July 2020 (40)
  • June 2020 (72)
  • May 2020 (46)
  • April 2020 (59)
  • March 2020 (46)
  • February 2020 (28)
  • January 2020 (36)
  • December 2019 (22)
  • November 2019 (11)
  • October 2019 (36)
  • September 2019 (44)
  • August 2019 (77)
  • July 2019 (117)
  • June 2019 (106)
  • May 2019 (49)
  • April 2019 (47)
  • March 2019 (24)
  • February 2019 (37)
  • January 2019 (12)
  • ARTICLES & NEWS

    • Business Continuity
    • Disaster Recovery
    • Crisis Management & Communications
    • Risk Management
    • Article Archives
    • Industry News

    THE JOURNAL

    • Digital Edition
    • Advertising & Media Kit
    • Submit an Article
    • Career Spotlight

    RESOURCES

    • White Papers
    • Rules & Regulations
    • FAQs
    • Glossary of Terms
    • Industry Groups
    • Business & Resource Directory
    • Business Resilience Decoded
    • Careers

    EVENTS

    • Fall 2023
    • Spring 2024

    WEBINARS

    • Watch Now
    • Upcoming

    CONTACT

    • Article Submission
    • Media Kit
    • Contact Us

    ABOUT DRJ

    Disaster Recovery Journal is the industry’s largest resource for business continuity, disaster recovery, crisis management, and risk management, reaching a global network of more than 138,000 professionals. Offering weekly webinars, the latest industry news, rules and regulations, podcasts, the industry’s only official mentoring program, a quarterly magazine, and two annual live conferences, DRJ is leading the way to keep professionals up-to-date and connected in an ever-changing world.

    LEARN MORE

    TWITTER

    Disaster Recovery Journal is the leading publication/event covering business continuity/disaster recovery.

    Follow us for daily updates @drjournal

    Newsletter

    The Journal, right in your inbox.

    Be informed and stay connected by getting the latest in news, events, webinars and whitepapers on Business Continuity and Disaster Recovery.

    Subscribe Now
    Copyright 2023 Disater Recovery Journal
    • Terms of Use
    • Privacy Policy